Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,866 GBX | -.--% |
|
-.--% | +0.21% |
10/06 | Dechra Pharmaceuticals Limited Appoints Jonathan David Lang as Director | CI |
15/04 | Dechra Pharmaceuticals Limited acquired 33.34% stake in STEM Animal Health Inc. | CI |
Sales 2022 | 682M 863M 72.01B | Sales 2023 | 762M 964M 80.43B | Capitalization | 4.2B 5.31B 443B |
---|---|---|---|---|---|
Net income 2022 | 58M 73.42M 6.13B | Net income 2023 | -27M -34.18M -2.85B | EV / Sales 2022 | 5.8 x |
Net Debt 2022 | 208M 264M 21.99B | Net Debt 2023 | 430M 544M 45.42B | EV / Sales 2023 | 6.08 x |
P/E ratio 2022 |
64.8
x | P/E ratio 2023 |
-150
x | Employees | - |
Yield 2022 |
1.3% | Yield 2023 |
0.34% | Free-Float | 0% |
6 months | +0.68% | ||
Current year | +0.21% |
![Extreme 3853.3425](/images/extremecours_fleche.png)
![Extreme 3618](/images/extremecours_fleche.png)
![Extreme 2473.323](/images/extremecours_fleche.png)
![Extreme 2030](/images/extremecours_fleche.png)
![Extreme 680.5](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Ian Page
CEO | Chief Executive Officer | 63 | 13/97/13 |
Paul Sandland
DFI | Director of Finance/CFO | 44 | 01/10/01 |
Jamie Adams
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Page
CEO | Chief Executive Officer | 63 | 13/97/13 |
Alison Platt
CHM | Chairman | - | 01/20/01 |
John Shipsey
BRD | Director/Board Member | - | 01/22/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
8.11% | 1 M€ | -.--% | ||
0.08% | 775 M€ | -.--% | - |
- Stock Market
- Equities
- DPH Stock